# Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment

> **NCT03422601** · — · UNKNOWN · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group** · enrollment: 1122 (actual)

## Conditions studied

- Colorectal Cancer
- Stage III Colon Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Immunoscore test

## Key facts

- **NCT ID:** NCT03422601
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-13
- **Primary completion:** 2019-06-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 1122 (ACTUAL)
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422601, "Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03422601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*